12-51702881-G-A
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PS1PM1PM2PM5PP2PP3_ModeratePP5_Moderate
The NM_001330260.2(SCN8A):c.1101G>A(p.Met367Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M367V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001330260.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 13Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile convulsions and choreoathetosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN8A | NM_001330260.2 | c.1101G>A | p.Met367Ile | missense_variant | Exon 9 of 27 | ENST00000627620.5 | NP_001317189.1 | |
| SCN8A | NM_014191.4 | c.1101G>A | p.Met367Ile | missense_variant | Exon 9 of 27 | ENST00000354534.11 | NP_055006.1 | |
| SCN8A | NM_001177984.3 | c.1101G>A | p.Met367Ile | missense_variant | Exon 9 of 26 | NP_001171455.1 | ||
| SCN8A | NM_001369788.1 | c.1101G>A | p.Met367Ile | missense_variant | Exon 9 of 26 | NP_001356717.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN8A | ENST00000354534.11 | c.1101G>A | p.Met367Ile | missense_variant | Exon 9 of 27 | 1 | NM_014191.4 | ENSP00000346534.4 | ||
| SCN8A | ENST00000627620.5 | c.1101G>A | p.Met367Ile | missense_variant | Exon 9 of 27 | 5 | NM_001330260.2 | ENSP00000487583.2 | ||
| SCN8A | ENST00000599343.5 | c.1101G>A | p.Met367Ile | missense_variant | Exon 8 of 26 | 5 | ENSP00000476447.3 | |||
| SCN8A | ENST00000355133.7 | c.1101G>A | p.Met367Ile | missense_variant | Exon 8 of 25 | 1 | ENSP00000347255.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Pathogenic:1
This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 367 of the SCN8A protein (p.Met367Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with seizure (Invitae). ClinVar contains an entry for this variant (Variation ID: 461331). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN8A protein function with a positive predictive value of 95%. This variant disrupts the p.Met367 amino acid residue in SCN8A. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at